Experiences of specific IgE in asthma due to diisocyanates
- PMID: 2854010
- DOI: 10.1111/j.1365-2222.1988.tb02911.x
Experiences of specific IgE in asthma due to diisocyanates
Abstract
The specific IgE antibodies were studied with the Phadebas RAST technique in 35 patients with asthma due to diisocyanates. Two had been sensitized to toluene diisocyanate (TDI), 17 to methylene diisocyanate (MDI) and 16 to hexamethylene diisocyanate (HDI). In each case the diagnosis was confirmed with a bronchial provocation test (BPT). The asthmatic reaction was immediate in 17 cases, of which three had also a late reaction (dual). Eighteen patients reacted only with a late reaction. Seven (20%) had specific IgE to diisocyanates. All RAST-positive patients had an immediate asthmatic reaction. None of the late reactors and referents had positive RASTs. RAST inhibition tests with 94-100% inhibition confirmed the specificity of the method. There was cross-reactivity between different diisocyanates, however. The patients with positive RAST to diisocyanates had a higher level of total IgE than the RAST negative group and the referents.
Similar articles
-
Specific IgE antibodies in twenty-eight workers with diisocyanate-induced bronchial asthma.Clin Allergy. 1984 Sep;14(5):453-61. doi: 10.1111/j.1365-2222.1984.tb02229.x. Clin Allergy. 1984. PMID: 6091945
-
Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma.Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):516-22. doi: 10.1164/ajrccm.162.2.9909026. Am J Respir Crit Care Med. 2000. PMID: 10934080
-
Asthma caused by diphenylmethane diisocyanate in foundry workers. Clinical, bronchial provocation, and immunologic studies.Am Rev Respir Dis. 1983 Aug;128(2):226-30. doi: 10.1164/arrd.1983.128.2.226. Am Rev Respir Dis. 1983. PMID: 6881681
-
The development of an animal model for TDI asthma.Bull Eur Physiopathol Respir. 1987 Nov-Dec;23(6):571-6. Bull Eur Physiopathol Respir. 1987. PMID: 2456109 Review.
-
Current diagnostic methods for diisocyanate induced occupational asthma.Am J Ind Med. 1999 Oct;36(4):459-68. doi: 10.1002/(sici)1097-0274(199910)36:4<459::aid-ajim7>3.0.co;2-w. Am J Ind Med. 1999. PMID: 10470011 Review.
Cited by
-
Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease?Clin Exp Allergy. 2010 Aug;40(8):1155-62. doi: 10.1111/j.1365-2222.2010.03550.x. Epub 2010 Jun 7. Clin Exp Allergy. 2010. PMID: 20545707 Free PMC article. Review.
-
Biological and genetic markers in occupational asthma.Curr Allergy Asthma Rep. 2015 Jan;15(1):488. doi: 10.1007/s11882-014-0488-7. Curr Allergy Asthma Rep. 2015. PMID: 25430950 Review.
-
Circulating miRs-183-5p, -206-3p and -381-3p may serve as novel biomarkers for 4,4'-methylene diphenyl diisocyanate exposure.Biomarkers. 2019 Feb;24(1):76-90. doi: 10.1080/1354750X.2018.1508308. Epub 2018 Dec 12. Biomarkers. 2019. PMID: 30074411 Free PMC article.
-
Occupational asthma due to isocyanates.Lung. 1996;174(1):23-30. doi: 10.1007/BF00167948. Lung. 1996. PMID: 8746999 Review. No abstract available.
-
Histamine release and inflammatory cell infiltration in airway Mucosa in methylene diphenyl diisocyanate (MDI)-induced occupational asthma.J Clin Immunol. 2008 Sep;28(5):571-80. doi: 10.1007/s10875-008-9199-y. Epub 2008 May 17. J Clin Immunol. 2008. PMID: 18484168